Effects of Androgen Withdrawal on the Stem Cell Composition of the Shionogi Carcinoma

Cancer Research

Volumn 50, Issue 8, 1990, Pages 2275-2282

  Bruchovsky, Nicholas ^a,d   Rennie, Paul S ^a,c   Goldenberg, S Larry ^a,c   Lawson, Dona ^a   To, Mary ^a   Coldman, Andrew J ^b  

^a Department of Cancer Endocrinology ^*  (Canada)

^b Division of Epidemiology ^*  (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; TESTOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST CARCINOMA; CANCER RECURRENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHIONOGI CARCINOMA; STEM CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANDROGENS; ANIMAL; CELL NUCLEUS; DNA, NEOPLASM; FEMALE; KINETICS; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED STRAINS; ORCHIECTOMY; RECEPTORS, ANDROGEN; STANOLONE; SUPPORT, NON-U.S. GOV'T;

EID: 0025246690     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Minesita, T., and Yamaguchi, T. An androgen-dependent mouse mammary tumor. Cancer Res., 25: 1168–1175, 1965.
2. Bruchovsky, N. The metabolism of testosterone and dihydrotestosterone in an androgen-dependent tumour. A possible correlation between dihydrotestosterone and tumour growth in vivo. Biochem. JM 127: 561–575, 1972.
3. Kitamura, Y., Okamoto, S., Uchida, N., Yamaguchi, K., and Matsumoto, K. Effect of androgen depletion on growth and androgen dependency of Shionogi carcinoma 115. Cancer Res., 38: 4711–4716, 1978.
4. Bruchovsky, N., Rennie, P. S., Otal, N., Vanson, A., Giles, M., and Pontifex, H. Variability of androgen-related phenotypes in the Shionogi mammary carcinoma during growth, involution, recurrence, and progression to hormonal independence. Cancer Res., 45: 682–689, 1985.
5. Kitamura, Y., Okamoto, S., Hayata, I., Uchida, N., Yamaguchi, K., and Matsumoto, K. Development of androgen-independent spindle cell tumors from androgen-dependent medullary Shionogi carcinoma 115 in androgen-depleted nude mice. Cancer Res., 39: 4713–4719, 1979.
6. Narita, N., Nakao, K., Uchida, N., Yamaguchi, K., Okamoto, S., Kitamura, Y., and Matsumoto, K. Effect of androgen depletion on postoperative re-growth of androgen-dependent and independent Shionogi carcinomas in mice. Gann, 71: 501–506, 1980.
7. Miyauchi, T., Wakisaka, M., Hara, S., Matsuzaki, O., and Shimazaki, J. Relapse of androgen-dependent tumour of mouse (Shionogi carcinoma 115) after castration and oestrogen treatment. Urol. Res., 11: 63–67, 1983.
8. Hara, S., Ichikawa, T., Akimoto, S., Wakisaka, M., and Shimazaki, J. Modalities of chemotherapy and endocrine therapy for growth inhibition of androgen-stimulated mouse carcinoma (Shionogi carcinoma 115). Prostate, 11: 107–115, 1987.
9. Bruchovsky, N., Sutherland, D. J., Meakin, J. W., and Minesita, T. Androgen receptors: relationship to growth response and to intracellular androgen transport in nine variant lines of the Shionogi mouse mammary carcinoma. Biochim. Biophys. Acta, 381: 61–71, 1975.
10. Bruchovsky, N., and Rennie, P. S. Classification of dependent and autonomous variants of Shionogi mammary carcinoma based on heterogeneous patterns of androgen binding. Cell, 13: 273–280, 1978.
11. Noguchi, S., Kitamura, Y., Uchida, N., Yamaguchi, K., Sato, B., and Matsumoto, K. Growth-stimulative effect of estrogen on androgen-dependent Shionogi carcinoma 115. Cancer Res., 44: 5644–5649, 1984.
12. Noguchi, S., Takatsuka, D., Kitamura, Y., Terada, N., Uchida, N., Yamaguchi, K., Sato, B., and Matsumoto, K. Mechanism of estrogen enhancement in the growth of androgen-dependent Shionogi carcinoma 115. Cancer Res., 45: 4785–4790, 1985.
13. Noguchi, S., Nishizawa, Y., Uchida, N., Yamaguchi, K., Sato, B., Kitamura, Y., and Matsumoto, K. Stimulative effect of physiological doses of androgen or pharmacological doses of estrogen on growth of Shionogi carcinoma 115 in mice. Cancer Res., 45: 5746–5750, 1985.
14. Darbre, P. D., and King, R. J. B. Differential effects of steroid hormones on parameters of cell growth. Cancer Res., 47: 2937–2944, 1987.
15. Omukai, Y., Nakamura, N., Hiraoka, D., Nishizawa, Y., Uchida, N., Noguchi, S., Sato, B., and Matsumoto, K. Growth-stimulating effect of pharmacological doses of glucocorticoid on androgen-responsive Shionogi carcinoma 115 in vivo in mice and in cell culture. Cancer Res., 47: 4329–4334, 1987.
16. Hiraoka, D., Nakamura, N., Nishizawa, Y., Uchida, N., Noguchi, S., Matsumoto, K., and Sato, B. Inhibitory and stimulatory effects of glucocorticoid on androgen induced growth of murine Shionogi carcinoma-induced growth of murine Shionogi carcinoma 115 in vivo and in cell culture. Cancer Res., 47: 6560–6564, 1987.
17. Foulds, L. Neoplastic Development. Vol. 1, pp. 69–76. New York: Academic Press, Inc., 1969.
18. Noble, R. L. Hormonal control of growth and progression in tumors of Nb rats and a theory of action. Cancer Res., 37: 82–94, 1977.
19. Bruchovsky, N., and Goldie, J. H. Basis for the use of drug and hormone combinations in the treatment of endocrine-related cancer. In: N. Bruchovsky and J. H. Goldie (eds.), Drug and Hormone Resistance in Neoplasia, Clinical Concepts, Vol. 2, pp. 129–162. Boca Raton, FL: CRC Press, 1983.
20. Bruchovsky, N., Brown, E. M., Coppin, C. M., Goldenberg, S. L., Le Riche, J. C., Murray, N. C., and Rennie, P. S. The endocrinology and treatment of prostate tumor progression. In: D. S. Coffey, N. Bruchovsky, W. A. Gardner, Jr., M. I. Resnick, and J. P. Karr (eds.), Current Concepts and Approaches to the Study of Prostate Cancer, pp. 347–387. New York: Alan R. Liss, Inc., 1987.
21. Uchida, N., Yamaguchi, K., Narita, N., Nakao, K., Kitamura, Y., and Matsumoto, K. Adjuvant chemo-endocrine therapy for androgen-dependent mammary tumor in mice. Breast Cancer Res. Treat., 1: 69–75, 1981.
22. Yoshikawa, T., Kitamura, Y., Uchida, N., Yamaguchi, K., and Matsumoto, K. Effect of adjuvant endocrine and adjuvant chemoendocrine therapies on metastasis of androgen-dependent Shionogi carcinoma 115. Cancer Res., 43: 4525–4529, 1983.
23. Emerman, J. T., and Siemiatkowski, J. Effects of endocrine regulation of growth of a mouse mammary tumor on its sensitivity to chemotherapy. Cancer Res., 44: 1327–1332, 1984.
24. Minesita, T., and Yamaguchi, K. An androgen-dependent tumor derived from a hormone-independent spontaneous tumor of a female mouse. Steroids, 4: 815–830, 1964.
25. Thames, H. D., Jr. Direct analysis of tumor control data. In: R. F. Kallman (ed.), Rodent Tumor Models in Experimental Cancer Therapy, pp. 103–105. New York: Pergamon Press, 1987.
26. Bruchovsky, N., Rennie, P. S., Batzold, F. H., Goldenberg, S. L., Fletcher, T., and McLoughlin, M. G. Kinetic parameters of 5 alpha-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates. J. Clin. Endocrinol. Metab., 67: 806–816, 1988.
27. Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248–254, 1976.
28. Burton, K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J., 62: 315–323, 1956.
29. Foekens, J. A., Rennie, P. S., Cheng, H., and Bruchovsky, N. In situ cross-linking of androgen receptors to nuclear acceptor sites of rat prostate with formaldehyde. J. Biol. Chem., 260: 10093–10098, 1985.
30. Munson, P. J., and Rodbard, D. Ligand: a versatile computerized approach for characterization of ligand binding systems. Anal. Biochem., 107: 220–239, 1980.
31. Segel, I. H. Enzyme Kinetics: Behaviour and Analysis of Rapid Equilibrium and Steady State Enzyme Systems. New York: John Wiley & Sons, 1975.
32. Krishan, A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol., 66: 188–193, 1975.
33. Hiddemann, W., Schumann, J., Andreeff, M., Barlogie, B., Herman, C. J., Leif, R. C., Mayall, B. H., Murphy, R. F., and Sandberg, A. A. Convention on nomenclature for DNA cytometry. Cytometry, 5: 445–446, 1984.
34. Simpson-Herren, L., and Lloyd, H. H. Kinetic parameters and growth curves for experimental tumor systems. Cancer Chemother. Rep., 54: 143–174, 1970.
35. Scatchard, G. The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci., 51: 660–672, 1949.
36. Bruchovsky, N., Lesser, B., Van Doom, E., and Craven, S. Hormonal effects on cell proliferation in rat prostate. Vitam. Horm., 33: 61–102, 1975.
37. Sanford, N. L., Searle, J. W., and Kerr, J. F. R. Successive waves of apoptosis in the rat prostate after repeated withdrawal of testosterone stimulation. Pathology, 76: 406–410, 1984.
38. Zama, S., Akimoto, S., Yazawa, S., Ichikawa, T., Hayata, I., Petrow, V., and Shimazaki, J. Androgen receptor, testosterone uptake, and karyotype in androgen-dependent mouse tumor (SCI 15) and its androgen-independent subline (CS2). Endocrinol. Jpn., 34: 279–289, 1987.
39. Jung-Testas, I., Desmond, W., and Baulieu, E.-E. Two sex steroid receptors in SC-115 mammary tumor cells. Exp. Cell. Res., 97: 219–232, 1976.
40. Stanley, R. E., Palmer, R. E., and Sohn, U. Development of methods for the quantitative in vivo analysis of androgen-dependent and autonomous Shionogi carcinoma 115 cells. Cell, 10: 35–44, 1977.
41. Emerman, J. T., and Kalousek, D. K. Flow cytometric and karyotypic analyses of androgen-responsive and androgen-independent Shionogi mouse mammary tumours. Cell Biol. Int. Rep., 11: 881–886, 1987.
42. Buttyan, R., Zakeri, Z., Lockshin, R., and Wolgemuth, D. Cascade induction of c-fos, c-myCy and heat shock 70k transcripts during regression of the rat ventral prostate gland. Mol. Endocrinol., 2: 650–657, 1988.
43. Quarmby, V. E., Beckman, W. C., Jr., Wilson, E. M., and French, F. S. Androgen regulation of c-myc messenger ribonucleic acid levels in rat ventral prostate. Mol. Endocrinol., 81: 865–874, 1987.
44. Rennie, P. S., Bruchovsky, N., Buttyan, R., Benson, M., and Cheng, H. Gene expression during the early phases of regression of the androgen-dependent Shionogi mouse mammary carcinoma. Cancer Res., 48: 6309–6312, 1988.
45. Montpetit, M. L., Lawless, K. R., and Tenniswood, M. Androgen-repressed messages in the rat ventral prostate. Prostate, 8: 25–36, 1986.
46. Nonomura, N., Nakamura, N., Uchida, N., Noguchi, S., Sato, B., Sonoda, T., and Matsumoto, K. Growth-stimulatory effect of androgen-induced autocrine growth factor(s) secreted from Shionogi carcinoma 115 cells on androgen-unresponsive cancer cells in a paracrine fashion. Cancer Res., 48: 4904–4908, 1988.
47. Bruchovsky, N., and Lesser, B. Control of proliferative growth in androgen responsive organs and neoplasms. In: R. L. Singhal, and J. A. Thomas (eds.), Cellular Mechanisms Modulating Gonadal Hormone Action, pp. 1–55. Baltimore: University Park Press, 1976.